linjc16/ctgov huggingface dataset:
Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension

Study Overview
=================
Brief Summary
-----------------
Assessment of the prognostic value of the estimation of plasma volume or its variation in patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) after acute right heart failure.

Detailed Description
-----------------
The aim of the study is to show that a low plasma volume status, assessed by the Strauss (estimated plasma volume variation) and the Duarte (instantaneous estimated plasma volume) formulas evaluated during acute right heart failure in patients presenting with PAH or CTEPH, is associated with better long-term outcomes. Optimization of plasma volume is important for patients with PAH and CTEPH and constitutes a prognostic factor. However, plasma volume status can be difficult to assess in clinical practice. Different formulas have been developed and have shown interest in patients with congestive heart failure with an association between plasma volume estimation and long-term prognosis. Acute right heart failure may occur in patients with PAH and CTEPH. Thus, the investigators plan to study the prognostic value of these formulas evaluating plasma volume, in patients with PAH or CTEPH, after acute right heart failure.

Official Title
-----------------
Assessment of the Prognostic Value of the Estimation of Plasma Volume or Its Variation in Patients With Pulmonary Arterial Hypertension (PAH) or Chronic Thromboembolic Pulmonary Hypertension (CTEPH) After Acute Right Heart Failure

Conditions
-----------------
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Acute Right Heart Failure

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with confirmed diagnosis of PAH or CTEPH, referred to the medical department of the investigators Patient with acute right heart failure defined by at least 2 of the following clinical features: worsening of peripheral oedema, development or increase of ascites, weight gain of more than 2.5 kg in 1 week preceding the visit and decline in one NYHA functional class compared to the previous stable state Exclusion Criteria: 1) Patients with another cause of pulmonary hypertension than PAH or CTEPH, either groups 2, 3 or 5 of the current clinical classification of pulmonary hypertension

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Survival | Death | From the first visit to 1st April 2023 | 
| Recurrence of acute right heart failure | Hospital admission for acute right heart failure | From the first visit to 1st April 2023 | 
| Acute right heart failure-free survival | First event: death or hospital admission for acute right heart failure | From the first visit to 1st April 2023 |
Prevalence and Risk Factors of Anxiety and Depression Among Policemen During the Health Crisis Linked to COVID-19

Study Overview
=================
Brief Summary
-----------------
To date, there is little international data on depression and anxiety among police officers apart from studies carried out after an attack or natural disaster. At the national level, no mental health data exists for police officers, apart from those from the Paris attacks, and the work of investigators after the Strasbourg attack (article in press). During the covid crisis, in Alsace, the police, like the rest of the population, took the full brunt of the pandemic. The police, however, are part of essential professions and have not been confined, but on the contrary, have remained in contact with the population, in particular to carry out traffic controls. Studies published to date show varying mental health outcomes for essential occupations during the pandemic. The investigators hypothesize that the police officers had a feeling of being more exposed and that their mental health could be affected. For this it was decided to compare two populations of departments of similar size, but with different exposure to the pandemic: Bas Rhin and Hérault French departments

Official Title
-----------------
Prevalence and Risk Factors of Anxiety and Depression in Two Populations of Policemen During the Health Crisis Linked to COVID-19

Conditions
-----------------
COVID-19, Anxiety Syndrome, Depression Syndrome, Policemen

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Any major agent in office in June 2020 of the national police of the Bas Rhin department, and Hérault Supported between June and September 2020 Subject not opposing, after information, the reuse of their data for the purposes of this research Exclusion Criteria: Subject having expressed his opposition to his data being reused for study purposes

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of depression and anxiety among policemen from two regions differently exposed to COVID 19 |  | 6 months after the covid crisis | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Covid-19, Anxiety Syndrome, Depression Syndrome, Covid crisis, Police officers
Effect of Compression Dressing After Upper Eyelid Blepharoplasty on Edema, Ecchymosis, Pain and Ocular Surface Irritation

Study Overview
=================
Brief Summary
-----------------
Study to analyze whether there is a difference in postoperative outcome regarding edema, ecchymosis, pain, OSI and discomfort of the patients after blepharoplasty if a compression dressing is used or not.

Official Title
-----------------
Effect of Compression Dressing After Upper Eyelid Blepharoplasty on Edema, Ecchymosis, Pain and Ocular Surface Irritation

Conditions
-----------------
Dermatochalasis of Eyelid

Intervention / Treatment
-----------------
* Device: Compression dressing


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with upper eyelid dermatochalasis who were scheduled for upper eyelid blepharoplasty Exclusion Criteria: previous surgery on the upper eyelid, previous eye lid trauma, congenital lid changes, blepharochalasis syndrome, coagulation disorders or indication for combined ptosis and blepharoplasty surgery

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: two arms. After randomization one eyelid of each patient was applied with a compression dressing, the other eyelid not.
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Compression dressing<br>Compression dressing was applied to one of the eyelids which was chosen by randomization postoperatively | Device: Compression dressing<br>* Application of dressing<br>|
| No Intervention: no dressing<br>No dressing was applied on the other eyelid (control group) | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Edema | Degree of edema postoperatively, rated on a four point rating scale: 0 = no, 1 = minimal, 2 = moderate, 3 = severe | Measures are taken the first day after surgery (D1), one week after surgery (D7) and eight weeks after surgery (D56) |
Comparisons of Human Fibrin Glue (Tisseel) Versus Suture and Robotic Versus Traditional Laparoscopy for Ovarian Cystectomy

Study Overview
=================
Brief Summary
-----------------
Objective: To compare the effects of suture versus human fibrin glue during robotic or laparoscopic ovarian cystectomy

Detailed Description
-----------------
Methods: The medical records of all consecutive women who received robotic or laparoscopic ovarian cystectomy between January 2016 and May 2022 were reviewed. Perioperative outcome and ovarian size were compared. Expected results: We can get the effects of suture versus human fibrin glue during robotic or laparoscopic ovarian cystectomy. The above information should be important for consultation.

Official Title
-----------------
Comparisons of Human Fibrin Glue (Tisseel) Versus Suture and Robotic Versus Traditional Laparoscopy for Ovarian Cystectomy

Conditions
-----------------
Women With Ovarian Cyst

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: >20 years old women women who received robotic or laparoscopic ovarian cystectomy between January 2016 and May 2022 were reviewed. Exclusion Criteria: Patients who underwent myomectomy at the same time.

Ages Eligible for Study
-----------------
Minimum Age: 20 Years

Sexes Eligible for Study
-----------------
Female

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Suture<br>Women with ovarian cyst who received robotic/laparoscopic ovarian cystectomy with suture | |
| Human Fibrin Glue<br>Women with ovarian cyst who received robotic/laparoscopic ovarian cystectomy with human fibrin glue | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Ovarian size | the ovarian size after ovarian cystectomy during follow-up | 24 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Blood loss | Estimated blood loss during perioperative period (including abdominal drainage) | 1 week |
Ultrasound-guided Blood Sampling Drawing for Microbiological Analysis in the Critically Ill

Study Overview
=================
Brief Summary
-----------------
This study will test the feasibility of ultrasound-guided sterile blood sampling for critically ill patients with suspected sepsis requiring blood culture. The aim of the study is to evaluate the feasibility and safety of the use of ultrasound for blood cultures in a population of patients which can present difficult venous access and requiring more than one venipuncture attempt in general clinical practice

Official Title
-----------------
Use of Ultrasound for Blood Sample Drawing for Microbiological Analysis in Critically Ill Patients:he ECOVEN Feasibility Study

Conditions
-----------------
Sepsis, Septic Shock, Infections, Diagnosis

Intervention / Treatment
-----------------
* Diagnostic Test: Ultrasound-guided venipuncture


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patients (18 year-old) admitted to intensive care unit suspected sepsis requiring blood cultrure Exclusion Criteria: pregnancy infections requiring respiratory isolation burns or skin disease involving arms and/or more than 60% of body surface

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patient requiring blood culture<br>After the request of treating physician of blood culture, each patient deemed eligible, will undergo the prescirbed couple of peripheral blood samples. The first one will be done with the classical blind technique, while the second one with ultrasound guidance. | Diagnostic Test: Ultrasound-guided venipuncture<br>* Venipuncture will be performed using ultrasound to identify the most appropriate vessel and guide the puncture<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of attempted venipunctures | Evaluation of the feasibility of ultrasound-guided venipuncture for blood samples in patients requiring ,microbiological analysis. Feasibility will be evaluated in terms of number of needed attempts of venipuncture | One hour after clinical decision of blood culture execution | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of possible complications (accidental arterial puncture, visible ematoma) | Evaluation of safety of venipuncture in terms of possible complications (accidental arterial puncture, ematoma) | One hour after clinical decision of blood culture execution | 
| Incidence of contamination of ultrasound-guided venipuncture | Evaluation of blood sample bacterial contamination compared to blind puncture | One hour after clinical decision of blood culture execution |
Is Size of Cisterna Magna Related to the Fetal Gender and Gestational Age

Study Overview
=================
Brief Summary
-----------------
The cisterna magna (CM) is a large subarachnoid cerebrospinal space that lies between the caudal aspect ofthe cerebellum and the medulla oblongata, drainingthe fourth ventricle . The evaluation of the fetal cisterna magna is animportant part of obstetric ultrasound which targetsdetection of prenatal malformation of the fetal centralnervous system (CNS).Therefore, measuring the size ofthe cisterna magna has important clinical significancefor diagnosing fetal nervous system abnormalities. Studies about the relationship between the anteroposterior diameter of the CM and the gestational age (GA) are still controversial. Some articles havepointed out that there was a good correlationbetween the diameter of the CM and GA

Detailed Description
-----------------
Prospective study that will include pregnant women who are between 20 weeks 0 days and 39 weeks 6 days of gestation. As in cross sectional study each fetus is considered only once. with use of magnetic resonance ultrasonography.( ultrasonography is a noninvasive imaging test uses high-frequency sound waves to create real-time pictures or video of internal organs or other soft tissues)

Official Title
-----------------
Is Size of Cisterna Magna Related to the Fetal Gender and Gestational Age

Conditions
-----------------
The Relationship Between the Anteroposterior Diameter of the CM and the Gestational Age and Gender

Intervention / Treatment
-----------------
* Behavioral: ultrasound observation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: 1- Pregnant women who are between 20 weeks 0 days and 39 weeks 6 days of gestation. 2.Singleton pregnancy is observed without visible abnormalities. Exclusion Criteria: 1 - .Pregnant women who are the exact gestational age can not be confirmed. 2. Fetal malformations or intrauterine growthretardation are detected. 3. Women with chronic diseases. 4. Increased bodymass index >30

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Pregnant women in male fetus<br> | Behavioral: ultrasound observation<br>* The relationship between the anteroposterior diameter of the CM and the gestational age and gender<br>|
| Pregnant women in female fetus<br> | Behavioral: ultrasound observation<br>* The relationship between the anteroposterior diameter of the CM and the gestational age and gender<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Relation of cisterna magna size to the gender and gestational age |  | 48 months |
Insulin Resistance in Atopic Dermatitis Patients

Study Overview
=================
Brief Summary
-----------------
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis.

Detailed Description
-----------------
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis. EASI and SCORAD values and disease duration of atopic dermatitis patients are calculated during the examination. HOMA-IR blood test result is compared with the results.

Official Title
-----------------
The Relationship Between Insulin Resistance and Disease Severity and Duration in Atopic Dermatitis Patients

Conditions
-----------------
Atopic Dermatitis

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Atopic dermatitis patients confirmed by a dermatologist Exclusion Criteria: patients younger than 2 years patients older than 80 years Atopic dermatitis patients without HOMA-IR result

Ages Eligible for Study
-----------------
Minimum Age: 2 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| HOMA-IR | Patients' blood test show the result of fasting insulin (microU/L) x fasting glucose (mmol/L)/22.5 | 12 months | 
| SCORAD index | Severity scoring of atopic dermatitis is calculated for each patient in the study. 6 intensity items (erythema, edema/papulation, oozing/crusts, excoriations, lichenification, dryness); 2 subjective symptoms(itch, sleeplessness); body surface area are studied. Max score is 103. | 12 months | 
| EASI index | Eczema Area and Severity Index is calculated for each patient in the study. Body surface area, 4 intensity items(erythema, induration, excoriation, lichenification) are studied. Max score is 72. | 12 months | 
| Duration of the disease | The time from the first onset of symptoms of the disease to the present. The relationship between insulin resistance and disease duration is examined | 12 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
atopic dermatitis, insulin resistance
A Study of AI in Cardiac Transplant in Echocardiographic Analysis (ORACLE)

Study Overview
=================
Brief Summary
-----------------
The purpose of this research is to detect episodes of rejection versus non-rejection after cardiac transplant and the diagnostic accuracy of an Artificial Intelligence (AI) algorithm using the data from an ECG (electrocardiogram) and Cardiac Ultrasound (Echocardiogram and/or point of care ultrasound).

Official Title
-----------------
Outcome Reflection for Immune Mediated Rejection by Utilizing Artificial Intelligence in Cardiac Transplant Patients Through Early and Late Echocardiographic Analysis (ORACLE)

Conditions
-----------------
Cardiac Transplant Rejection

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients undergoing post-cardiac transplant endomyocardial biopsy, and the ability to provide informed consent and a consent for the study. Exclusion Criteria: Refusal of study participation

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of episodes identified by the Artificial Intelligence (AI) algorithm as 1R or greater acute cellular rejection, grade 1 or greater antibody mediated rejection, reduction in LVEF to <50%, or a drop in LVEF >5% | Number of episodes identified by the AI algorithm as 1R or greater acute cellular rejection, grade 1 or greater antibody mediated rejection, reduction in LVEF to <50%, or a drop in LVEF >5% utilizing electrocardiograms and cardiac ultrasound images/videos obtained from point of care ultrasound (POCUS) or echocardiograms. | 2 years |
Social Media Impact on Patients' Regarding Aesthetic Dental Treatments

Study Overview
=================
Brief Summary
-----------------
The aim of this observational study was to describe dental patients the use of social media related to aesthetic dental treatments. The main questions it aims to answer were: Describe the use of social media before undergoing an aesthetic treatment. To assess the influence of social media prior to undergoing aesthetic treatment Participants answered a web-base questionnaire.

Detailed Description
-----------------
In recent years, an increased use of social media has been observed. Therefore, the aim of this observational study is to describe the use of social media in dental patients in relation to aesthetic dental treatments, as well as, its possible influence. A 25-question questionnaire was designed with the following 4 sections: (i) informed consent; (ii) demographic characteristics; (iii) cosmetic dental treatments; and (iv) social media use.

Official Title
-----------------
Social Media Impact on Patients' Decision-Making Regarding Aesthetic Dental Treatments: A Web-Based Questionnaire Study

Conditions
-----------------
Social Media, Dentist-Patient Relations

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Over 18 years old that use social media Exclusion Criteria: Not having undergone any aesthetic dental treatment

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Use of social media | Percentage of participants that used social media when undergoing aesthetic dental treatment | 3 minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Influence of social media | Percentage of participants that social media influenced them when undergoing aesthetic dental treatment | 3 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Social Media, Dentist-Patient Relations, Aesthetic dentistry